Co-Editor-in-Chief

Regional Editor for the Americas

DAVID R. SIBLEY
National Institute of Neurological
Disorders & Stroke, National
Institutes of Health, Bethesda, MD, USA

Regional Editor for Asia/Australia

AKIYOSHI FUKAMIZU
Center for Tsukuba Adcanced Research
Alliance (TARA), University of Tsukuba,
Tsukuba, Ibaraki, Japan

Editor Emeritus

VLADIMIR PLISKA
Institute of Pharmaceutical Sciences,
ETH Zurich-Irchel, Zurich, Switzerland

Editorial Board

Europe

E. BARNARD - Dept. of Pharmacology, University of Cambridge, Cambridge, UK
M. BIENERT - Institute of Molecular Pharmacology (EMP), Campus Berline-Buch, Berlin, Germany
J.-P. CHANGEUX - Laboratoire de neurobiologie moleculaire, Institut Pasteur, Paris, France
S. COTECCHIA - Institute of Pharmacology and Toxicology,University of Lausanne, Lausanne, Switzerland
P. N. E. DE GRAAN - Rudolph Magnus Institute of Neurosciences, University of Utrecht, Utrecht, Netherlands
G. FOLKERS - Institute of Pharmaceutical Sciences, ETH Zurich-Irchel, Zurich, Switzerland
M. HAMON - Neurobiologie functionelle, INSERM Unite 288, CPU Pitie-Salpetriere, Paris, France
D. HOYER - Nervous System Research, Novartis Pharma AG, Basel, Switzerland
K.-H. JAKOBS - Department of Pharmacology, University of Essen, Essen, Germany
L. JOSEE - Janssen Research Foundation Beerse, Belgium
G. KERI - Department of Medicinal Chemistry, Molecular Biology and Pathobiology, Semmelweis University, Budapest, Hungary
M. LAZDUNSKI - Institut de Pharmacologie Molecular et Cellulairs, University of Nice, Valbonne Sophi Antipolis, France
A. MAELICKE - Institute of Physiological Chemistry and Pathobiochemistry, University of Mainz, Mainz, Germany
A. NORTH - Institute of Molecular Physiology, University of Sheffield, Sheffield, UK
J. R. PASQUALINI - Steroid Hormone Research Unit, Institut de Periculture, Paris, France
V. PLISKA - Collegium Helveticum, ETH Zurich, Zurich, Switzerland
W. SCHLEGEL - Foundation pour Recherches Medicales, University of Geneve, Geneva, Switzerland
T. SCHWARTZ - Department of Pharmacology, The Panum Institute, University of Copenhagen, Copenhagen, Denmark

North America

J.BENOVIC - Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA, USA
L. BIRNBAUMER - Laboratory of Signal Transduction, National Institute of Environmental Health and Sciences, Research Triangle, Park, NC, USA
M. BIRNBAUMER - Laboratory of Signal Transduction, National Institute of Environmental Health and Sciences, Research Triangle Park, NC
R. BOND - Dept. of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, TX, USA
M. BOUVIER - Department of Biochemistry, University of Montreal, Montreal, Canada
M. O. CARON - Department of Cell Biology and Medicine, Duke University, Durham, NC, USA
O. CIVELLI - Department of Pharmacology, University of California, Irvine, CA, USA
W.P. CLARKE - Dept. of Pharmacology, University of Texas, San Antonio, TX, USA
B.M. COX - School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
M. DUFAU - National Institute of Child Health & Human Development (NICHD), National Institutes of Health, Bethesda, MD, USA
E. ESCHER - Dept. of Pharmacology, University of California, San Diego, CA, USA
J.S. FLIER - Department of Medicine, Division of Endocrinology & Metabolism, Beth Israel Hospital, Boston, MA, USA
R.L. HUGANIR - Department of Neurosciences, Howard Hughes Medical Institute, John Hopkins University, Baltimore, MD, USA
P.A. INSEL - Department of Pharmacology, University of California, San Diego, CA, USA
C.R. KAHN - Research Division, Joslin Diabetes Center, Boston, MA, USA
J.A. KATZENELLENBOGEN - Department of Chemistry, University of Illinois, Urbana, IL, USA
J.M. LINDSTROM - Department of Neurosciences, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
R.B. MIKKELSEN - Department of Radiation Oncology, Virginia Commonwealth University, Box 58, Richmond, VA, USA
K.A. NEVE - Research Service, VA Medical Center, Portland, OR USA
D. PEREZ - Dept. of Molecular Cardiology, Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
B.L. ROTH - Department of Biochemistry, Case Western Reserve University, Medical School, Cleveland, OH, USA
N.P. SHANKLEY - RW Johnson Pharmaceutical Research Institute, San Diego, CA, USA
F.I. TARAZI - McLean Hospital, Harvard Medical School, Belmont, MA, USA
C. TOWNSEND - Systems Research, GlaxoSmithKline, Research Triangle, Park, NC, USA
J. WESS - National Institute of Diabetes & Digestive & Kidney Disorders (NIDDK), National Institutes of Health, Bethesda, MD, USA
J. WORLEY - Vertex Pharmaceuticals, San Diego, CA, USA

Asia and Australia

Y. KASUYA - Department of Biochemistry, Chiba University, Chiba, Japan
K. MIKOSHIBA - Dept. of Molecular Neurobiology, University of Tokyo, Tokyo, Japan
Y. MINAMI - Medical School, University of Kobe, Kobe, Japan
N. MOCHIZUKI - Research Institute, National Cardiovascular Center, Osaka, Japan
T. OHTAKI - Pharmaceutical Research Division, Takeda Chemical Industries, Ltd., Tsukuba, Japan
G.. PEI - Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China
Y. TANAKA - University of Occupational and Environmental Health, Kitakyushu, Japan
W. G. THOMAS - Molecular Endocrinology Laboratory, Baker Heart Research Institute, Melbourne, Australia
S. YAMADA - School of Pharmaceutical Sciences, University fo Shizuoka, Shizuoka, Japan